Clinical Trials
12 trialsNCT07509034 2026-05-27
Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
National Institutes of Health Clinical Center (CC)
Phase 1 Not yet recruiting
NCT07607925 2026-05-27
A Study to Evaluate Safety and Clinical Activity of GSK5926371 in Adult Participants With Relapsed or Refractory B-NHL
GlaxoSmithKline
Phase 1/2 Not yet recruiting
NCT07609823 2026-05-27
A Phase 2 Study of Lacutoclax (LP-108) in Patients With Relapsed/Refractory CLL/SLL
Guangzhou Lupeng Pharmaceutical Company LTD.
Phase 2 Not yet recruiting
NCT07607327 2026-05-26
FORWARD
CareDx
Not yet recruiting
NCT07601607 2026-05-22
Lisaftoclax Plus Chidamide and Rituximab in Relapsed or Refractory Diffuse Large B-cell Lymphoma
Sun Yat-sen University
Phase 1/2 Not yet recruiting
NCT07198945 2026-05-14
STARLING
Indiana University
Phase NA Not yet recruiting
NCT07586618 2026-05-14
ALT-101
Allterum Therapeutics, Inc
Phase 1 Not yet recruiting
NCT07572695 2026-05-07
Salvage Haploidentical HSCT With DLI and Targeted Therapy for R/R AML
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Not yet recruiting
NCT07574346 2026-05-07
IASO207 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies
Peking University People's Hospital
Phase EARLY_PHASE1 Not yet recruiting
NCT07570407 2026-05-06
QiNKT-HSCT
University Hospital Pilsen
Not yet recruiting
NCT06970496 2026-05-05
A Clinical Trial of B019 Injection in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.
Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.
Phase 1 Not yet recruiting
NCT07567469 2026-05-05
A Safety and Efficacy Study of Combined Fianlimab + Cemiplimab in Children and Young Adults With Recurrent or Progressive High-Grade Glioma or Posterior Fossa-A Ependymoma
Regeneron Pharmaceuticals
Phase 1/2 Not yet recruiting